Bio-Rad Laboratories, Inc. (NYSE:BIO) Given Average Rating of “Buy” by Brokerages
Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) have been given a consensus recommendation of “Buy” by the four analysts that are presently covering the stock, Marketbeat Ratings reports. Four analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have issued ratings on the […]
More Stories
Kaiser Aluminum (NASDAQ:KALU) Announces Earnings Results
Kaiser Aluminum (NASDAQ:KALU – Get Free Report) issued its earnings results on Wednesday. The industrial products company reported $0.51 EPS...
Ausbil Investment Management Ltd Purchases 1,721 Shares of Atmos Energy Co. (NYSE:ATO)
Ausbil Investment Management Ltd raised its stake in shares of Atmos Energy Co. (NYSE:ATO – Free Report) by 2.4% during...
Argent Capital Management LLC Buys 282 Shares of LCI Industries (NYSE:LCII)
Argent Capital Management LLC raised its stake in LCI Industries (NYSE:LCII – Free Report) by 14.5% during the third quarter,...
Ausbil Investment Management Ltd Buys 8,031 Shares of Modine Manufacturing (NYSE:MOD)
Ausbil Investment Management Ltd grew its position in shares of Modine Manufacturing (NYSE:MOD – Free Report) by 42.8% in the...
PG&E Co. (NYSE:PCG) Shares Acquired by Ausbil Investment Management Ltd
Ausbil Investment Management Ltd increased its position in shares of PG&E Co. (NYSE:PCG – Free Report) by 6.0% during the...
ESSA Bancorp Reports Financial Results for September 30, 2024
ESSA Bancorp, Inc., a Pennsylvania-based company, disclosed its financial outcomes for the period ending September 30, 2024. The announcement was...